RPT-J&J says offered $2.1 bln for Lifescan diabetes business

16 Mar 2018

March 16 (Reuters) – Johnson & Johnson said on
Friday that private investment firm Platinum Equity had offered
to buy its LifeScan Inc diabetes care business for about $2.1
billion.

Read full article at Reuters